Skip to main content
OpenTrials

Clinical trial condition

Melanoma

Explore clinical trials studying Melanoma. Study availability and eligibility vary by location and protocol.

2,209 public trials 376 recruiting studies
Refine in advanced search Browse all conditions

Melanoma trial results

Completed

A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer, Non-small Cell Lung Cancer, or Melanoma That Has Spread to the Brain

NCT02308020

Conditions
Brain Diseases, Brain Metastases, Brain Neoplasms, +28 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • University of California - San Diego La Jolla, California, United States
  • Univ of California San Francisco San Francisco, California, United States
  • John Wayne Cancer Institute Santa Monica, California, United States
View all 44 locations
View Trial Details
Completed

A Study to Evaluate RAF265, an Oral Drug Administered to Subjects With Locally Advanced or Metastatic Melanoma

NCT00304525

Conditions
Melanoma, Metastatic Melanoma, Neoplasms, +10 more
Locations
  • University of Colorado Univ.ofColoradoCancerCenter Aurora, Colorado, United States
  • Georgia Regents University Cancer Clinical Research Unit Augusta, Georgia, United States
  • Sidney Kimmel Comprehensive Cancer Center/Johns Hopkins Med. Medical Oncology Baltimore, Maryland, United States
  • Massachusetts General Hospital Dept of Cancer for Melanoma Boston, Massachusetts, United States
View Trial Details
Completed

A Safety and Efficacy Study of Multiple Administration Regimens for Nivolumab Plus Ipilimumab in Subjects With Melanoma

NCT02905266

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • Melanoma Institute Australia North Sydney, New South Wales, Australia
  • Greenslopes Private Hospital Greenslopes, Queensland, Australia
  • Cabrini Hospital Malvern, Victoria, Australia
  • Local Institution Lyon, France
View all 16 locations
View Trial Details
Completed

In Situ, Autologous Therapeutic Vaccination Against Solid Cancers With Intratumoral Hiltonol®

NCT02423863

Conditions
Head and Neck Cancer, Head and Neck Neoplasms, Melanoma, +14 more
Locations
  • Chevy Chase RCCA Chevy Chase, Maryland, United States
  • Dermatologic Surgery Center Washington DC Chevy Chase, Maryland, United States
  • Bay Hematology Oncology Easton, Maryland, United States
  • University of Missouri School of Medicine Columbia, Missouri, United States
View Trial Details
Completed

Long-Term Quality of Life in Patients With Metastatic Melanoma Treated With Checkpoint Inhibitors

NCT03326973

Conditions
Melanoma, Metastatic Melanoma, Neoplasms, +10 more
Locations
  • Memoral Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Memoral Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Commack Commack, New York, United States
  • Memorial Sloan Kettering Westchester Harrison, New York, United States
View Trial Details
Completed

A Study to Test the Benefit of a New Anti-cancer Treatment in Patients With Unresectable Advanced Melanoma

NCT00942162

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site Orange, California, United States
  • GSK Investigational Site Orlando, Florida, United States
View all 63 locations
View Trial Details

Related conditions